Shareholders' equity · 2015–2025
Organogenesis Holdings shareholders' equity
$300M+14.2% · FY2025
Organogenesis Holdings (ORGO) reported $300M in shareholders' equity for fiscal 2025, +14.2% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $300M | +14.2% | Open → |
| FY20242024-12-31 | $263M | −5.7% | Open → |
| FY20232023-12-31 | $279M | +4.9% | Open → |
| FY20222022-12-31 | $266M | +10.1% | Open → |
| FY20212021-12-31 | $241M | +70.2% | Open → |
| FY20202020-12-31 | $142M | +172.6% | Open → |
| FY20192019-12-31 | $52.0M | +30.3% | Open → |
| FY20182018-12-31 | $39.9M | +$55.3M | Open → |
| FY20172017-12-31 | −$15.3M | +$662,000 | Open → |
| FY20162016-12-31 | −$16.0M | −$19.5M | Open → |
| FY20152015-12-31 | $3.5M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +56.0%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Organogenesis Holdings shareholders' equity |url=https://companiesranked.com/en/company/organogenesis-holdings/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Organogenesis Holdings shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/organogenesis-holdings/shareholders-equityBibTeX
@misc{companiesranked-en-company-organogenesis-holdings-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Organogenesis Holdings shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/organogenesis-holdings/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-338049 · August 6, 2026
{{cite web |title=Organogenesis Holdings shareholders' equity — 10-Q (0001193125-26-338049) |url=https://www.sec.gov/Archives/edgar/data/1661181/000119312526338049/orgo-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.